PTHS Pelthos Therapeutics Inc.
$7.15
Pelthos Therapeutics Inc. (PTHS) Earnings News
Earnings press releases, previews and reviews for Pelthos Therapeutics Inc. (PTHS), newest first. Our most recent is review: Pelthos Misses as Zelsuvmi Stalls Sequentially, and the Castle Creek Pivot Raises the Stakes for a Balance Sheet Already Under Strain.
Thursday
November 12, 2026
10:54 AM ET
Pelthos Misses as Zelsuvmi Stalls Sequentially, and the Castle Creek Pivot Raises the Stakes for a Balance Sheet Already Under Strain
Earnings Whispers · Review
Thursday
November 12, 2026
7:00 AM ET
Pelthos Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update
Thursday
November 5, 2026
11:48 AM ET
Pelthos Faces a Seasonal Test of Zelsuvmi Momentum as Stock Sits Near Lows
Earnings Whispers · Preview
Wednesday
November 4, 2026
4:05 PM ET
Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026
Thursday
August 13, 2026
7:10 AM ET
Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
Monday
August 3, 2026
8:00 AM ET
Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026